Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
12.3M
-
Shares change
-
-2.57M
-
Total reported value, excl. options
-
$26M
-
Value change
-
-$34.5M
-
Number of buys
-
30
-
Number of sells
-
-30
-
Price
-
$2.11
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q1 2022
82 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q1 2022.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.3M shares
of 142M outstanding shares and own 8.7% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (2.55M shares), FRANKLIN RESOURCES INC (1.6M shares), BlackRock Inc. (1.36M shares), Knoll Capital Management, LLC (1.08M shares), FMR LLC (903K shares), Rock Springs Capital Management LP (702K shares), VANGUARD GROUP INC (611K shares), STATE STREET CORP (426K shares), Artal Group S.A. (400K shares), and GEODE CAPITAL MANAGEMENT, LLC (288K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.